[1]苏舒,唐刚华,向贤宏,等.肝纤维化分子显像的研究进展[J].国际放射医学核医学杂志,2017,41(4):265-270.[doi:10.3760/cma.j.issn.1673-4114.2017.04.006]
 Su Shu,Tang Ganghua,Xiang Xianhong,et al.The research progress of molecular imaging of liver fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(4):265-270.[doi:10.3760/cma.j.issn.1673-4114.2017.04.006]
点击复制

肝纤维化分子显像的研究进展(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
41
期数:
2017年第4期
页码:
265-270
栏目:
综述
出版日期:
2017-07-25

文章信息/Info

Title:
The research progress of molecular imaging of liver fibrosis
作者:
苏舒1 唐刚华2 向贤宏1 聂大红3
1. 510080, 广州, 中山大学附属第一医院医学影像科;
2. 510080, 广州, 中山大学附属第一医院广东省医用放射性药物转化应用工程技术研究中心医学影像科;
3. 510080, 广州, 中山大学附属第一医院放射治疗科
Author(s):
Su Shu1 Tang Ganghua2 Xiang Xianhong1 Nie Dahong3
1. Department of Medicine Imaging, the First Affliated Hospital, Sun Yat-sen University, Guangzhou 510080, China;
2. Department of Medicine Imaging, Conversion and Application of Medical Radiological Drug Engineering Technology Research Center, the First Affliated Hospital, Sun Yat-sen University, Guangzhou 510080, China;
3. Department of Radiotherapy, the First Affliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
关键词:
磁共振成像体层摄影术发射型计算机单光子正电子发射断层显像术肝纤维化
Keywords:
Magnetic resonance imagingTomographyemission-computedsingle-photonPositron-emission tomographyLiver fibrosis
DOI:
10.3760/cma.j.issn.1673-4114.2017.04.006
摘要:
肝纤维化是一种伴随慢性肝病的病理过程,具有较高的发病率和病死率。目前诊断肝纤维化的金标准是肝活检术,但肝活检术有其局限性,且目前尚无有效的无创诊断肝纤维化的手段。在肝纤维化的早期阶段,其可通过治疗“逆转”,因此,肝纤维化的诊断和精确分期在控制该疾病中非常重要。由于分子影像学技术具有无创、特异度高等优点,因此其发展具有巨大潜力。笔者对磁共振分子影像学技术和核医学分子影像学技术在肝纤维化诊断和分期方面的最新进展进行概述。
Abstract:
Hepatic fibrosis is a pathological process associated with chronic liver diseases,with significant morbidity and mortality.The current gold standard for the diagnosis of liver fibrosis is liver biopsy,but liver biopsy has many limitations.Currently,there is no noninvasive means of effective diagnosis of liver fibrosis.In the early stages of the disease,it can be reversed by active therapy.Thus,diagnosis and precise stages of liver fibrosis are important in controlling progression of the disease.Because of its noninvasive,high specificity and other advantages,molecular imaging has great potential use in liver fibrosis.This paper provides an overview of the latest advances in the diagnosis and stages of liver fibrosis using magnetic resonance imaging and nuclear medicine imaging.

参考文献/References:

[1] Mallat A, Lotersztajn S. Cellular mechanisms of tissue fibrosis.5.Novel insights into liver fibrosis[J]. Am J Physiol Cell Physiol, 2013, 305(8):C789-C799. DOI:10.1152/ajpcell.00230.2013.
[2] Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis:a meta-analysis[J]. Gastroenterology, 2008, 134(4):960-974. DOI:10.1053/j.gastro.2008.01.034.
[3] Cohen EB, Afdhal NH. Ultrasound-based hepatic elastography:origins, limitations, and applications[J]. J Clin Gastroenterol, 2010, 44(9):637-645. DOI:10.1097/MCG.0b013e3181e12c39.
[4] Bakan AA, Inci E, Bakan S, et al. Utility of diffusion-weighted imaging in the evaluation of liver fibrosis[J]. Eur Radiol, 2012, 22(3):682-687. DOI:10.1007/s00330-011-2295-z.
[5] Sandrasegaran K, Akisik FM, Lin C, et al. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis[J]. AJR Am J Roentgenol, 2009, 193(6):1556-1560. DOI:10.2214/AJR.09.2436.
[6] Wang YX, Yuan J, Chu ES, et al. T1rho MR imaging is sensitive to evaluate liver fibrosis:an experimental study in a rat biliary duct ligation model[J]. Radiology, 2011, 259(3):712-719. DOI:10.1148/radiol.11101638.
[7] Allkemper T, Sagmeister F, Cicinnati V, et al. Evaluation of fibrotic liver disease with whole-liver T1ρ MR imaging:a feasibility study at 1.5T[J]. Radiology, 2014, 271(2):408-415. DOI:10.1148/radiol.13130342.
[8] Zhao F, Wang YX, Yuan J. MR T1rho as an imaging biomarker for monitoring liver injury progression and regression:an experimental study in rats with carbon tetrachloride intoxication[J]. Eur Radiol,2012, 22(8):1709-1716. DOI:10.1007/s00330-012-2419-0.
[9] Wang Y, Ganger DR, Levitsky J, et al. Assessment of chronic hepatitis and fibrosis:comparison of MR elastography and diffusionweighted imaging[J]. AJR Am J Roentgenol, 2011, 196(3):553-561.DOI:10.2214/AJR.10.4580.
[10] Wang QB, Zhu H, Liu HL, et al. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis:A meta-analysis[J].Hepatology, 2012, 56(1):239-247.DOI:10.1002/hep.25610.
[11] Thng CH, Koh TS, Collins DJ, et al. Perfusion magnetic resonance imaging of the liver[J]. World J Gastroenterology, 2010, 16(13):1598-1609. DOI:10.3748/wjg.v16.i13.1598.
[12] Mankoff DA. A definition of molecular imaging[J]. J Nucl Med, 2007, 48(6):18N, 21N.
[13] Hayashi H, Sakai T.Animal models for the study of liver fibrosis:new insights from knockout mouse models[J]. Am J Physiol Gastrointest Liver Physiol, 2011, 300(5):G729-G738. DOI:10.1152/ajpgi.00013.2011.
[14] Polasek M, Fuchs BC, Uppal R, et al. Molecular MR imaging of liver fibrosis:a feasibility study using rat and mouse models[J]. J Hepatol, 2012, 57(3):549-555. DOI:10.1016/j.jhep.2012.04.035.
[15] Dodig M, Ogunwale B, Dasarathy S, et al. Differences in regulation of type I collagen synthesis in primary and passaged hepatic stellate cell cultures:the role of alpha5beta1-integrin[J]. Am J Physiol Gastrointest Liver Physiol, 2007, 293(1):G154-G164. DOI:10.1152/ajpgi.00432.2006.
[16] Ehling J, Bartneck M, Fech V, et al. Elastin-based molecular MRI of liver fibrosis[J]. Hepatology, 2013, 58(4):1517-1518. DOI:10.1002/hep.26326.
[17] Vithanarachchi SM, Allen MJ. Strategies for Target-Specific contrast agents for magnetic resonance imaging[J]. Curr Mol Imaging, 2012, 1(1):12-25. DOI:10.2174/2211555211201010012.
[18] Ge PL, Du SD, Mao YL. Advances in preoperative assessment of liver function[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(4):361-370. DOI:10.1016/S1499-3872(14)60267-8.
[19] Eo JS, Paeng JC, Lee DS. Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation[J]. World J Gastroenterol, 2014, 20(18):5375-5388. DOI: 10.3748/wjg.v20.i18.5375.
[20] Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion:RGD and integrins[J]. Science, 1987, 238(4826):491-497. DOI:10.1126/science.2821619.
[21] Zhou X, Murphy FR, Gehdu N. Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells[J]. J Biol Chem, 2004, 279(23):23996-24006. DOI:10.1074/jbc.M311668200.
[22] Li F, Song Z, Li Q. Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrin alphavbeta3 expression with SPECT in rat[J]. Hepatology, 2011, 54(3):1020-1030. DOI:10.1002/hep.24467.
[23] Zhang X, Xin J, Shi Y, et al. Assessing activation of hepatic stellate cells by (99m)Tc-3PRGD2 scintigraphy targeting integrin αvβ3:a feasibility study[J]. Nucl Med Biol, 2015, 42(3):250-255. DOI:10.1016/j.nucmedbio.2014.11.007.
[24] Guo Z. Simultaneous SPECT imaging of multi-targets to assist in identifying hepatic lesions[J]. Sci Rep, 2016, 6:28812.DOI:10.1038/srep28812.
[25] Hernandez-Martinez A, Marin-Oyaga VA, Salavati A. Quantitative assessment of global hepatic glycolysis in patients with cirrhosis and normal controls using 18F-FDG-PET/CT:a pilot study[J]. Ann Nucl Med, 2014, 28(1):53-59. DOI:10.1007/s12149-013-0780-y.
[26] Kao HW, Chen CL, Chang WY, et al. 18F-FBHGal for asialoglyco-protein receptor imaging in a hepatic fibrosis mouse model[J].Bioorg Med Chem, 2013, 21(4):912-921. DOI:10.1016/j.bmc.2012. 12.022.
[27] Han TT, Du M, Zhang X, et al. Quantitative assessment of early liver fibrosis in rats using 13N-NH3·H2O PET/CT[J]. Nucl Med Commun, 2016, 37(1):92-98. DOI:10.1097/MNM.0000000000000415.
[28] Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases[J]. Cytokine Growth Factor Rev, 2004, 15(4):255-273. DOI:10. 1016/j.cytogfr.2004.03.006.
[29] Beljaars L, Weert B, Geerts A,et al. The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue[J]. Biochem Pharmacol,2003, 66(7):1307-1317. DOI:10.1016/S0006-2952(03)00445-3.
[30] Beljaars L, Molema G, Weert B, et al. Albumin modified with mannose 6-phosphate:A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells[J]. Hepatology, 1999, 29(5):1486-1493. DOI:10.1002/hep.510290526.
[31] Cutrera J, Dibra D, Xia X, et al. Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy[J]. Mol Ther, 2011, 19(8):1468-1477. DOI:10.1038/mt.2011.38.
[32] Greupink R, Bakker HI, Bouma W, et al. The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo[J]. J Pharmacol Exp Ther, 2006, 317(2):514-521.DOI:10.1124/jpet.105. 099499.
[33] Zeng W, Wang X, Xu P, et al. Molecular imaging of apoptosis:from micro to macro[J]. Theranostics, 2015, 5(6):559-582. DOI:10.7150/thno.11548.
[34] 黄婷婷, 王红亮, 唐刚华. 细胞凋亡小分子PET显像剂的研究进展[J]. 同位素, 2011, 24(4):240-245. Huang TT, Wang HL, Tang GH. Research progress of small-molecule PET probes for apoptosis imaging[J]. J Isotopes, 2011, 24(4):240-245.

相似文献/References:

[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
 Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
 Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
 Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[4]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
 Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[5]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
 Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[6]李敏,蒋涛,彭朋,等.直肠内注入模拟粪便的动态MRI对女性盆底痉挛综合征的诊断价值[J].国际放射医学核医学杂志,2016,40(3):165.[doi:10.3760/cma.j.issn.1673-4114.2016.03.001]
 Li Min,Jiang Tao,Peng Peng,et al.Value of dynamic MRI with rectum injection in the diagnosis of female spastic pelvic floor syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):165.[doi:10.3760/cma.j.issn.1673-4114.2016.03.001]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
 Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]唐令胜,刘朝晖,李红梅,等.低场磁共振DWI技术与常规MRI扫描对超急性脑梗死的诊断灵敏度的比较[J].国际放射医学核医学杂志,2016,40(3):187.[doi:10.3760/cma.j.issn.1673-4114.2016.03.006]
 Tang Lingsheng,Liu Zhaohui,Li Hongmei,et al.Comparison of the diagnostic sensitivity of low-field magnetic resonance diffusion weighted imaging technology and conventional MRI scanning for super acute cerebral infarction[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):187.[doi:10.3760/cma.j.issn.1673-4114.2016.03.006]
[9]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[10]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
 You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[11]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
 Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[12]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
 Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[13]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
 Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[14]马春旭,袁卫红.甲状腺结节影像学诊断研究进展[J].国际放射医学核医学杂志,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
 Ma Chunxu,Yuan Weihong.Advanced research on imaging diagnosis of thyroid nodule[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
[15]刘纯宝,兰晓莉,张永学.粥样硬化易损斑块传统影像与分子影像检测与评价现状[J].国际放射医学核医学杂志,2014,38(2):101.[doi:10.3760/cma.j.issn.1673-4114.2014.02.008]
 Liu Chunbao,Lan Xiaoli,Zhang Yongxue.Current situation of detection and evaluation for atherosclerosis vulnerable plaque by conventional imaging and molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):101.[doi:10.3760/cma.j.issn.1673-4114.2014.02.008]
[16]戴娜,吴翼伟.影像学技术在霍奇金淋巴瘤诊疗中的价值[J].国际放射医学核医学杂志,2014,38(2):117.[doi:10.3760/cma.j.issn.1673-4114.2014.02.011]
 Dai Na,Wu Yiwei.The value of medical imaging methods in diagnosis and treatment of Hodgkin lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):117.[doi:10.3760/cma.j.issn.1673-4114.2014.02.011]
[17]党连荣,南雅炫,裴慧杰,等.脑裂畸形的CT、MRI影像学征象分析[J].国际放射医学核医学杂志,2014,38(4):239.[doi:10.3760/cma.j.issn.1673-4114.2014.04.008]
 Dang Lianrong,Nan Yaxuan,Pei Huijie,et al.Analysis of the CT and MRI imaging features of schizencephaly[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):239.[doi:10.3760/cma.j.issn.1673-4114.2014.04.008]
[18]刘辰,杨悦,张雪宁,等.CT/MRI图像融合在前列腺癌IMRT中的应用进展[J].国际放射医学核医学杂志,2014,38(4):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
 Liu Chen,Yang Yue,Zhang Xuening,et al.CT/MRI image fusion in intensity modulated radiation therapy for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
[19]许东,丛英珍,王志军.MELAS型线粒体脑肌病伴基底节灰质核团对称性钙化一例[J].国际放射医学核医学杂志,2014,38(5):349.[doi:10.3760/cma.j.issn.1673-4114.2014.05.017]
[20]董佳佳,章斌.多种影像学方法评价乳腺癌新辅助化疗疗效的价值比较[J].国际放射医学核医学杂志,2014,38(6):427.[doi:10.3760/cma.j.issn.1673-4114.2014.06.018]
 Dong Jia-jia,Zhang Bin.Comparision on the values of different image modalities in monitoring the response to neoadjuvant chemotherapy in breast cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):427.[doi:10.3760/cma.j.issn.1673-4114.2014.06.018]

备注/Memo

备注/Memo:
收稿日期:2017-05-07。
基金项目:国家自然科学基金(81571704、81371584、81671719);广东省自然科学基金(2015A030313067);广东省科技计划项目(2013B021800264);广州市科技计划项目(201604020169)
通讯作者:唐刚华,Email:gtang0224@126.com
更新日期/Last Update: 2017-07-31